Open2.250 | Close- |
Vol / Avg.187.597K / 985.219K | Mkt Cap198.571M |
Day Range2.200 - 2.290 | 52 Wk Range1.475 - 8.730 |
Allakos Stock (NASDAQ: ALLK) stock price, news, charts, stock research, profile.
Open2.250 | Close- |
Vol / Avg.187.597K / 985.219K | Mkt Cap198.571M |
Day Range2.200 - 2.290 | 52 Wk Range1.475 - 8.730 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.450 | -0.520 | -0.0700 | ||||
REV | 0 |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.480 | -0.410 | 0.0700 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-11-28 | JMP Securities | Jonathan Wolleben | Reiterates | Market OutperformMarket Outperform | Maintains | - | 10.00 |
2023-11-14 | JMP Securities | Jonathan Wolleben | Maintains | Market OutperformMarket Outperform | Lowers | 11.00 | 10.00 |
2023-11-14 | Barclays | Carter Gould | Maintains | UnderweightUnderweight | Lowers | 2.50 | 1.50 |
2023-09-27 | JMP Securities | Jonathan Wolleben | Initiates Coverage On | Market Outperform | Announces | - | 11.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ALLK | Allakos | 2.25% | 198.6M |
ZURA | Zura Bio | 0% | 209M |
IPHA | Innate Pharma | 2.5% | 198.3M |
IMRX | Immuneering | 5.48% | 202.5M |
ARQT | Arcutis Biotherapeutics | 1.09% | 175.6M |
You can purchase shares of Allakos (NASDAQ: ALLK) through any online brokerage.
Other companies in Allakos’s space includes: Zura Bio (NASDAQ:ZURA), Innate Pharma (NASDAQ:IPHA), Immuneering (NASDAQ:IMRX), Arcutis Biotherapeutics (NASDAQ:ARQT) and Opthea (NASDAQ:OPT).
The latest price target for Allakos (NASDAQ: ALLK) was reported by JMP Securities on Tuesday, November 28, 2023. The analyst firm set a price target for 10.00 expecting ALLK to rise to within 12 months (a possible 340.53% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Allakos (NASDAQ: ALLK) is $2.27 last updated Today at December 1, 2023 at 3:45 PM UTC.
There is no dividend information for Allakos.
Allakos’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Allakos.
Allakos is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.